Uveitis Withdrawn Phase 2 Trials for Ranibizumab (DB01270)

Also known as: Unspecified iridocyclitis / Uveitis NOS / Uveitis (disorder)

IndicationStatusPhase
DBCOND0009937 (Uveitis)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00846625Study of Uveitic Macular Edema Treated With Ranibizumab or SteroidsTreatment